Status:
COMPLETED
Oxytocin Administration During Cesarean Section
Lead Sponsor:
Assiut University
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
20-40 years
Phase:
PHASE4
Brief Summary
Cesarean delivery is defined as fetal birth through incisions in the abdominal wall and the uterine wall. This definition does not include removal of the fetus from the abdominal cavity in the case of...
Eligibility Criteria
Inclusion
- Primigravida or multigravida
- Term (37 - 42 weeks),
- Singleton pregnancies
- Booked for elective caesarean section.
- Accepting to participate in the study.
Exclusion
- • Medical disorders involving the heart, liver, kidney or brain.
- Diabetes mellitus and hypertension.
- Blood disorders (e.g. coagulopathies, thrombocytopenia)
- Patients requiring blood transfusion due to anemia.
- Risk factors for uterine atony e.g. macrosomia, polyhydramnios and multiple pregnancy.
- Previous 2 or more cesarean section
- Placenta previa or placental abruption
- Previous major obstetric haemorrhage (\>1000 ml) in previous deliveries.
- Known fibroid or adenomyosis.
- Women who received anticoagulant therapy.
- Severe preeclampsis.
- Uterine anomalies.
Key Trial Info
Start Date :
October 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03344302
Start Date
October 1 2016
End Date
September 1 2017
Last Update
April 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut Faculty of Medicine
Asyut, Egypt